Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion type Assertion NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_head.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion description "[The baculovirus-expressed rIgG1 13B8.2 antibody led to 14% to 40% proliferation inhibition of the lymphoblastic leukaemia-derived SUP-T1, the acute T lymphoma-derived CCRF-CEM and Jurkat, and the cutaneous T-Cell lymphoma-derived HUT-78 cell lines, but it did not affect the cell cycle nor induce cell apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_provenance.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion evidence source_evidence_literature NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_provenance.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion SIO_000772 17471166 NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_provenance.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion wasDerivedFrom befree-20140225 NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_provenance.
- NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_assertion wasGeneratedBy ECO_0000203 NP641947.RAvAMz0ImwNqVm61htnMJ43tlNW7d1rnuFEd9Z836bMDw130_provenance.